Trial Design
This trial was a parallel 2-group RCT with 1:1 randomization to either an intervention or control group. Participants were assessed at baseline before randomization. Outcome assessments were performed at 4 months after inclusion (after the end of intervention, some assessments were performed between 4 and 5 months) and again at 12 months after inclusion. Full details are provided in the trial protocol in 